Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

Epistaxis

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Identification of microprotein-coding intronic polyadenylation isoforms and function in genotoxic anticancer drug response.

Genome biology·2025

Same author

Compartment-specific and ELAVL1-coordinated regulation of intronic polyadenylation isoforms by doxorubicin.

Genome research·2022

Same author

At the crossroads of RNA biology, genome integrity and cancer.

Bulletin du cancer·2022

Same author

Assessment of presumed small-molecule ligands of telomeric i-DNA by biolayer interferometry (BLI).

Chemical communications (Cambridge, England)·2022

Same author

Access to a stabilized i-motif DNA structure through four successive ligation reactions on a cyclopeptide scaffold.

Organic & biomolecular chemistry·2020

Same author

Agents' pivotality and reward fairness modulate sense of agency in cooperative joint action.

Cognition·2019

Search research articles

Related Experiment Video

Updated: Jun 28, 2025

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

Published on: August 30, 2020

[Management of SAH].

Alexandre Devaux¹, Bénédicte Fustier¹

¹Service de réanimation neurochirurgicale (RNC), CHU Grenoble-Alpes, 38043 Grenoble Cedex 9, France.

Revue De L'Infirmiere

|April 21, 2024

Summary

Subarachnoid hemorrhage (SAH) is a common cause of cerebrovascular patient admissions to neurosurgical intensive care units. This article outlines the appropriate management strategies for SAH patients.

Keywords:

clinical sign hémorragie sous arachnoïdienne (HSA)monitoring neurosurgical resuscitation réanimation neurochirurgicale signe clinique subarachnoid hemorrhage (SAH)surveillance

More Related Videos

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Published on: June 18, 2021

A Murine Model of Subarachnoid Hemorrhage

A Murine Model of Subarachnoid Hemorrhage

Published on: November 21, 2013

Related Experiment Videos

Last Updated: Jun 28, 2025

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

Published on: August 30, 2020

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Published on: June 18, 2021

A Murine Model of Subarachnoid Hemorrhage

A Murine Model of Subarachnoid Hemorrhage

Published on: November 21, 2013

Area of Science:

Neurosurgery
Intensive Care Medicine
Cerebrovascular Diseases

Context:

Grenoble University Hospital's neurosurgical intensive care unit manages numerous cerebrovascular patients annually.
2023 data indicates subarachnoid hemorrhage (SAH) is a leading pathology treated.
SAH presents a significant clinical challenge in neurocritical care.

Purpose:

To detail the appropriate course of action for managing subarachnoid hemorrhage (SAH).
To provide guidance on the treatment protocols for SAH patients.
To enhance the understanding of SAH management in a neurosurgical intensive care setting.

Summary:

Subarachnoid hemorrhage (SAH) is a frequent cause of admission for cerebrovascular patients.
Analysis of 2023 data highlights the prevalence of SAH in neurosurgical intensive care.
The article focuses on the recommended management pathway for SAH.

Impact:

Improved patient outcomes through standardized SAH treatment.
Enhanced clinical decision-making for neurocritical care teams managing SAH.
Contribution to the body of knowledge on cerebrovascular disease management.